CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Theracal LC +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04397094
NCT04397094Phase 4Completed
CompareCT.gov

Theracal Versus Formocresol Pulpotomy in Primary Molars

Ain Shams University·interventional·Posted May 21, 2020·Updated Jul 29, 2020

In Brief

A Phase 4 clinical trial evaluating Theracal LC and Formocresol for Deep Caries. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDeep Caries
CountriesEgypt
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMay 21, 2020
Enrollment StartDec 1, 2017
Primary CompletionMar 17, 2018
Study CompletionMar 30, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.1 years ago

Interventions

Theracal LCdrug

pulpotomy

Formocresoldrug

Pulpotomy